1. Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.
- Author
-
Zhao XJ, Liu XL, Liang YM, Zhang S, Liu T, Li LB, Jiang WG, Chen JJ, Xu Q, Lv CL, Jiang BG, Kou ZQ, Wang GL, and Fang LQ
- Subjects
- Humans, Aged, Male, Female, Longitudinal Studies, China epidemiology, Antibodies, Neutralizing, Kinetics, Antibodies, Viral blood, Reinfection epidemiology, Immunization, Secondary, COVID-19 epidemiology, COVID-19 immunology, COVID-19 virology, COVID-19 Vaccines administration & dosage, SARS-CoV-2 classification, SARS-CoV-2 physiology
- Abstract
After the termination of zero-COVID-19 policy, the populace in China has experienced both Omicron BA.5 and XBB waves. Considering the poor antibody responses and severe outcomes observed among the elderly following infection, we conducted a longitudinal investigation to examine the epidemiological characteristics and antibody kinetics among 107 boosted elderly participants following the Omicron BA.5 and XBB waves. We observed that 96 participants (89.7%) were infected with Omicron BA.5, while 59 (55.1%) participants were infected with Omicron XBB. Notably, 52 participants (48.6%) experienced dual infections of both Omicron BA.5 and XBB. The proportion of symptomatic cases appeared to decrease following the XBB wave (18.6%) compared to that after the BA.5 wave (59.3%). Omicron BA.5 breakthrough infection induced lower neutralizing antibody titers against XBB.1.5, BA.2.86, and JN.1, while reinfection with Omicron XBB broadened the antibody responses against all measured Omicron subvariants and may alleviate the wild type-vaccination induced immune imprinting. Boosted vaccination type and comorbidities were the significant factors associated with antibody responses. Updated vaccines based on emerging severe acute respiratory syndrome coronavirus 2 variants are needed to control the Coronavirus Disease 2019 pandemic in the elderly., (© 2024 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF